The mayo clinic biobank: A building block for individualized medicine

Mayo Clinic Proceedings

Volumn 88, Issue 9, 2013, Pages 952-962

  Olson, Janet E ^a   Ryu, Euijung ^a   Johnson, Kiley J ^a   Koenig, Barbara A ^b   Maschke, Karen J ^c   Morrisette, Jody A ^a   Liebow, Mark ^a   Takahashi, Paul Y ^a   Fredericksen, Zachary S ^a   Sharma, Ruchi G ^a   Anderson, Kari S ^a   Hathcock, Matthew A ^a   Carnahan, Jason A ^a   Pathak, Jyotishman ^a   Lindor, Noralane M ^a   Beebe, Timothy J ^a   Thibodeau, Stephen N ^a   Cerhan, James R ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HASTINGS CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BIOBANK; BLOOD ANALYSIS; BREAST CANCER; ELECTRONIC MEDICAL RECORD; EUROPEAN AMERICAN; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH CARE FACILITY; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; HYPERTENSION; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DECISION MAKING; MEDICAL HISTORY; MELANOMA; NON MELANOMA SKIN CANCER; ORGAN PRESERVATION; OSTEOARTHRITIS; PERSONALIZED MEDICINE; PROSTATE CANCER; QUESTIONNAIRE; SELF REPORT; TISSUE SPECIMEN; TISSUES; UNITED STATES; UTERINE CERVIX CANCER;

EID: 84884648409     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mayocp.2013.06.006     Document Type: Article

References (33)

1. Giannini C, Oelkers MM, Edwards WD, et al. Maintaining clinical tissue archives and supporting human research: challenges and solutions. Arch Pathol Lab Med. 2011;135(3): 347-353.
2. Gaskell G, Gottweis H. Biobanks need publicity. Nature. 2011; 471(7337): 159-160.
3. McCarty CA, Wilke RA, Giampietro PF, Wesbrook SD, Caldwell MD. Marshfield Clinic Personalized Medicine Research Project (PMRP): design, methods and recruitment for a large population-based biobank. Personalized Med. 2005;2(1): 49-79.
4. Roden DM, Pulley JM, Basford MA, et al. Development of a large-scale de-identified DNA biobank to enable personalized medicine. Clin Pharmacol Ther. 2008;84(3): 362-369.
5. Scott CT, Caulfield T, Borgelt E, Illes J. Personal medicine: the new banking crisis. Nat Biotechnol. 2012;30(2): 141-147.
6. Gulcher J, Stefansson K. Population genomics: laying the groundwork for genetic disease modeling and targeting. Clin Chem Lab Med. 1998;36(8): 523-527.
7. MacLeod AK, Liewald DCM, McGilchrist MM, Morris AD, Kerr SM, Porteous DJ. Some principles and practices of genetic biobanking studies. Eur Respir J. 2009;33(2): 419-425.
8. Ollier W, Sprosen T, Peakman T. UK Biobank: from concept to reality. Pharmacogenomics. 2005;6(6): 639-646.
9. Zielhuis GA. Biobanking for epidemiology. Public Health. 2012; 126(3): 214-216.
10. O'Doherty KC, Hawkins AK, Burgess MM. Involving citizens in the ethics of biobank research: informing institutional policy through structured public deliberation. Soc Sci Med. 2012; 75(9): 1604-1611.
11. O'Doherty K, Gauvin FP, Grogan C, Friedman W. Implementing a public deliberative forum. Hastings Cent Rep. 2012;42(2): 20-23.
12. Avard D, Bucci LM, Burgess MM, et al. Public health genomics and public participation: points to consider. J Public Deliberation. 2009;5(1):article 7. http://www.publicdeliberation.net/jpd/vol5/ iss1/art7. Accessed August 7, 2013.
13. Secko DM, Preto N, Niemeyer S, Burgess MM. Informed consent in biobank research: a deliberative approach to the debate. Soc Sci Med. 2009;68(4): 781-789.
14. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36), I: conceptual framework and item selection. Med Care. 1992;30(6): 473-483.
15. Coates A, Fischer Dillenbeck C, McNeil DR, et al. On the receiving end, II: linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy. Eur J Cancer Clin Oncol. 1983;19(11): 1633-1637.
16. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32(6): 705-714.
17. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11): 1284-1292.
18. Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985;10(3): 141-146.
19. Chute CG, Beck SA, Fisk TB, Mohr DN. The Enterprise Data Trust at Mayo Clinic: a semantically integrated warehouse of biomedical data. J Am Med Inform Assoc. 2010;17(2): 131-135.
20. Pathak J, Murphy SP, Willaert BN, et al. Using RxNorm and NDF-RT to classify medication data extracted from electronic health records: experiences from the Rochester Epidemiology Project. AMIA Annu Symp Proc. 2011;2011: 1089-1098.
21. Zhong W, Maradit-Kremers H, St Sauver JL, et al. Age and sex patterns of drug prescribing in a defined American population [published online ahead of print June 11, 2013]. Mayo Clin Proc. http://dx.doi.org/10.1016/j.mayocp.2013. 04.021.
22. Clunie DA. DICOM structured reporting and cancer clinical trials results. Cancer Inform. 2007;4: 33-56.
23. Ruch P, Gobeill J, Lovis C, Geissbuhler A. Automatic medical encoding with SNOMED categories. BMC Med Inform Decis Mak. 2008;8(suppl 1):S6.
24. Centers for Disease Control and Prevention. 2011 Behavioral Risk Factor Surveillance System Survey. http://www.cdc.gov/ brfss/annual-data/annual-2011. htm. Accessed August 6, 2013.
25. Hurt RD, Weston SA, Ebbert JO, et al. Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws. Arch Intern Med. 2012;172(21): 1635-1641.
26. Nelson DE, Powell-Griner E, Town M, Kovar MG. A comparison of national estimates from the National Health Interview Survey and the Behavioral Risk Factor Surveillance System. Am J Public Health. 2003;93(8): 1335-1341.
27. Li C, Balluz LS, Ford ES, Okoro CA, Zhao G, Pierannunzi C. A comparison of prevalence estimates for selected health indicators and chronic diseases or conditions from the Behavioral Risk Factor Surveillance System, the National Health Interview Survey, and the National Health and Nutrition Examination Survey, 2007-2008. Prev Med. 2012;54(6): 381-387.
28. Collins R. What makes UK Biobank special? Lancet. 2012; 379(9822): 1173-1174.
29. Chen Z, Chen J, Collins R, et al. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol. 2011;40(6): 1652-1666.
30. 2010 Census. http://factfinder2.census.gov/faces/nav/jsf/pages/index. xhtml. Accessed August 7, 2013.
31. Ridgeway JL, Han LC, Olson JE, et al. Potential bias in the bank: what distinguishes refusers, non-responders and participants in a clinic-based biobank? Public Health Genomics. 2013;16(3): 118-126.
32. Swanson JM. The UK Biobank and selection bias. Lancet. 2012; 380(9837):110.
33. United States Census Bureau. American Factfinder. http://www.cdc.gov/ brfss/technical-infodata/surveydata/2011.htm. Accessed July 19, 2013.